Robert Kane
The US biotech, who specializes in developing cannabis products, hopes Kane will help to increase company exposure, access to capital, and ultimately increase share holder value through his new role.
Of his appointment, Kane said: “I am proud to be working with Cannabis Science to increase shareholders value for an organization that is truly on the front lines of this science of medicine."